Award

Guiding grocery carts to shape healthy habits

Robert Helsley receives Walter A. Shaw Young Investigator in Lipid Research Award
Marissa Locke Rottinghaus
Nov. 21, 2024

In a world of processed foods, a person could spend hours in a grocery store staring at confusing labels while trying to select the healthiest bread. But, imagine how easy grocery shopping would be if you could consult a personal dietician right there in the store.

Robert “Nate” Helsley
Robert “Nate” Helsley

Matching dieticians and shoppers at risk for cardiovascular disease is just one of the innovative clinical trials Robert “Nate” Helsley has managed. After growing up in rural Ohio and earning a Ph.D. in nutritional sciences at the University of Kentucky, Helsley said he understands how difficult it can be to choose healthy foods.

“Many of the issues are related to convenience and education,” he said. “For example, many people do not know how to appropriately read food labels … So, this was an opportunity to address those issues on the front line. That’s why I was excited about the job.”

After managing clinical trials for a few years, Helsley decided to return to the bench to help improve human health from the ground up.

Now an assistant professor of medicine at the UK College of Medicine, he works to identify the mechanisms that link nutrient metabolism to the development of cardiometabolic diseases. For this work, he won the American Society for Biochemistry and Molecular Biology’s 2025 Walter A. Shaw Young Investigator Award in Lipids, which recognizes outstanding lipid research by a young investigator.

Helsley said that his early work on clinical trials motivated his research to find therapeutics for diseases such as obesity, heart disease and liver cancer.

“There are still fundamental issues with how we treat obesity, which includes education, … accessibility of resources and healthy food options,” he said. “Seeing how dieticians could help these people really opened my eyes.”

Leveraging lipid levels to starve liver cancer

Robert “Nate” Helsley takes a nontraditional research approach: He first identifies a disease and then develops translational models to find potential therapeutics. His lab focuses on diseases of the liver. Metabolic dysfunction–associated steatotic liver disease, or MASLD, and metabolic dysfunction–associated steatohepatitis, or MASH, are two of the most common. Only one drug has been approved to treat these conditions, so researchers are pushing to find more and better treatments.

“Understanding how MASLD and MASH can progress to liver cancer is a huge need, especially over the next 15 to 20 years,” Helsley said.

Using human liver tissue samples, Helsley examined lipid levels in the tumor and in matched, nontumor samples. He found that monounsaturated fatty acids, made by the enzyme stearoyl-CoA desaturase, or SCD, accumulate in tumor tissue.

Other researchers are exploring SCD inhibitors as a therapeutic option, but Helsley wants to attack the pathway from the opposite end. His target: CPT1A, the enzyme responsible for breaking down, or oxidizing, monounsaturated fatty acids. His lab found that the CPT1A pathway shuts down in human liver tumors, allowing monosaturated fatty acids, the tumor’s food source, to build up.

Helsley’s plan is to deplete these fatty acids and starve the tumor.

“When the capacity to oxidize monounsaturated fatty acids is turned off, they build up,” Helsley said. “It’s like yin and yang. … If we can figure out a way to exploit that pathway and turn it on, we think we could further prevent tumor growth.”

Helsley will give a talk at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago, titled “The contribution of fatty acid oxidation to diet-induced hepatocellular carcinoma.”

ASBMB 2025 award winners

Read profiles of all the society’s 2025 honorees who will receive their awards and give talks at the ASBMB Annual Meeting, April 12–15 in Chicago.

From receptor research to cancer drug development: The impact of RTKs
Joseph Schlessinger receives the ASBMB Herbert Tabor Research Award.

Computational and biophysical approaches to disordered proteins
Rohit Pappu receives the DeLano Award for Computational Biosciences.

Leading the charge for gender equity
Nicole Woitowich receives the ASBMB Emerging Leadership Award.

Helping underrepresented scientists feel seen
Benjamin Garcia receives the ASBMB Ruth Kirschstein Diversity in Science Award.

Transforming learning through innovation and collaboration
Neena Grover receives the William C. Rose Award for Exemplary Contributions to Education.

Curiosity turned a dietitian into a lipid scientist
Judy Storch receives the Avanti Award in Lipids.

Elucidating how chemotherapy induces neurotoxicity
Andre Nussenzweig receives the Bert and Natalie Vallee Award.

What seems dead may not be dead
Vincent Tagliabracci receives the Earl and Thressa Stadtman Distinguished Scientist Award.

'You can't afford to be 15 years behind the parasite'
David Fidock receives the Alice and C.C. Wang Award in Molecular Parasitology.

Guiding grocery carts to shape healthy habits
Robert Helsley receives the Walter A. Shaw Young Investigator in Lipid Research Award.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Marissa Locke Rottinghaus

Marissa Locke Rottinghaus is the Editorial Content Manager for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

ASBMB names 2025 fellows
Announcement

ASBMB names 2025 fellows

Feb. 17, 2025

American Society for Biochemistry and Molecular Biology honors 24 members for their service to the society and accomplishments in research, education, mentorship, diversity and inclusion and advocacy.

When Batman meets Poison Ivy
Science Communication

When Batman meets Poison Ivy

Feb. 13, 2025

Jessica Desamero had learned to love science communication by the time she was challenged to explain the role of DNA secondary structure in halting cancer cell growth to an 8th-grade level audience.

The monopoly defined: Who holds the power of science communication?
Essay

The monopoly defined: Who holds the power of science communication?

Feb. 12, 2025

“At the official competition, out of 12 presenters, only two were from R2 institutions, and the other 10 were from R1 institutions. And just two had distinguishable non-American accents.”

In memoriam: Donald A. Bryant
In Memoriam

In memoriam: Donald A. Bryant

Feb. 10, 2025

He was a professor emeritus at Penn State University who discovered how cyanobacteria adapt to far-red light and was a member of the American Society for Biochemistry and Molecular Biology for over 35 years.

 Yes, I have an accent — just like you
Science Communication

 Yes, I have an accent — just like you

Feb. 6, 2025

When the author, a native Polish speaker, presented her science as a grad student, she had to wrap her tongue around the English term “fluorescence cross-correlation microscopy.”

Professorships for Booker; scholarship for Entzminger
Member News

Professorships for Booker; scholarship for Entzminger

Feb. 3, 2025

Squire Booker has been appointed to two honorary professorships at Penn State University. Inayah Entzminger received a a BestColleges scholarship to support their sixth year in the biochemistry Ph.D. program at CUNY.